Behavioral health ketamine compounds & end-to-end digital MTM

Explore behavioral health conditions we treat using ketamine in compounding

Behavioral health ketamine compounds are used to treat the following conditions:

Physical response of our body
Major Depression Disorder (MDD) is one of the most common mental illnesses in the US. According to the National Institue of Health, in 2020, the disorder affected roughly 21 million (8.4%) adults in the US. Prevalence of MDD is highest amongst those aged 18-25 and is higher among adult females compared to males. For some patients suffering from MDD, the disorder may impact one's quality of life and interfere with carrying out daily tasks. Depression can also lead to seizures by causing sleep deprivation. The relationship between depression and epilepsy is bidirectional.

Currently many treatment options for both MDD and Epilepsy exist including psychotherapy, pharmacotherapy, electroconvulsive therapy and bright light therapy. Treatment choice for patients should be individualized and coordinated with an interprofessional healthcare team for better outcomes. Selecting an effective compounded medication treatment for depression seizures may help improve symptoms based on specific needs of each patient.

Among drug classes we use for

behavioral health treatment:

Full-cycle provider support for continuous treatment improvement
How Mega Aid works How Mega Aid works
If you are the provider - book a remote meeting with a liaison to explore how you can improve your patient outcomes
Book a Meeting

Please, use our Contacts page to find a communication channel that suits your goals

Medical practice zip code

Preferable meeting time Optional fields

By clicking “Submit”, you agree to Mega Aid Terms of use and Privacy Policy

Discover Mega Aid video broadcasts to get the latest insights in the compounding industry and medication therapy management
Learn more how we work with physicians and hospitals
Learn more about compoundings and your medical treatment
Skip to content